Literature DB >> 28360967

Azelaic Acid Topical Formulations: Differentiation of 15% Gel and 15% Foam.

James Q Del Rosso1.   

Abstract

In this article, the author reviews topical formulations of azelaic acid used to treat papulopustular rosacea. Emphasis is placed on differences in vehicle technology and potential clinical impact of the possibility for neurosensory cutaneous tolerability reactions.

Entities:  

Year:  2017        PMID： 28360967      PMCID： PMC5367880     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


  25 in total

1.  Comprehensive medical management of rosacea: an interim study report and literature review.

Authors:  James Q Del Rosso; Eric W Baum
Journal:  J Clin Aesthet Dermatol       Date:  2008-05

2.  Comparison of 15% azelaic acid gel and 0.75% metronidazole gel for the topical treatment of papulopustular rosacea.

Authors:  Janusz Czernielewski; Yin Liu
Journal:  Arch Dermatol       Date:  2004-10

Review 3.  Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies.

Authors:  A S Breathnach
Journal:  Cutis       Date:  1996-01

Review 4.  Azelaic acid 15% gel in the treatment of rosacea.

Authors:  Harald Gollnick; Alison Layton
Journal:  Expert Opin Pharmacother       Date:  2008-10       Impact factor: 3.889

Review 5.  Kallikrein 5-mediated inflammation in rosacea: clinically relevant correlations with acute and chronic manifestations in rosacea and how individual treatments may provide therapeutic benefit.

Authors:  Aimee M Two; James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2014-01

6.  Azelaic acid foam 15% in the treatment of papulopustular rosacea: a randomized, double-blind, vehicle-controlled study.

Authors:  Zoe Diana Draelos; Boni Elewski; Gerald Staedtler; Blanka Havlickova
Journal:  Cutis       Date:  2013-12

7.  Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation.

Authors:  Arianna Mastrofrancesco; Monica Ottaviani; Nicaela Aspite; Giorgia Cardinali; Enzo Izzo; Klaus Graupe; Christos C Zouboulis; Emanuela Camera; Mauro Picardo
Journal:  Exp Dermatol       Date:  2010-07-02       Impact factor: 3.960

8.  Azelaic acid gel 15%: clinical versatility in the treatment of rosacea.

Authors:  James Q Del Rosso; Eric W Baum; Zoe Diana Draelos; Boni E Elewski; Alan B Fleischer; Lenore S Kakita; Diane Thiboutot
Journal:  Cutis       Date:  2006-11

9.  Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel.

Authors:  Alvin B Coda; Tissa Hata; Jeremiah Miller; David Audish; Paul Kotol; Aimee Two; Faiza Shafiq; Kenshi Yamasaki; Julie C Harper; James Q Del Rosso; Richard L Gallo
Journal:  J Am Acad Dermatol       Date:  2013-07-18       Impact factor: 11.527

10.  A phase 3 randomized, double-blind, vehicle-controlled trial of azelaic acid foam 15% in the treatment of papulopustular rosacea.

Authors:  Zoe Diana Draelos; Boni E Elewski; Julie C Harper; Meike Sand; Gerald Staedtler; Richard Nkulikiyinka; Kaweh Shakery
Journal:  Cutis       Date:  2015-07
View more
  3 in total

Review 1.  Managing Rosacea in the Clinic: From Pathophysiology to Treatment-A Review of the Literature.

Authors:  Sandra Marchese Johnson; Andrew Berg; Chelsea Barr
Journal:  J Clin Aesthet Dermatol       Date:  2020-04-01

2.  A novel azelaic acid formulation for the topical treatment of inflammatory rosacea: A multicentre, prospective clinical trial.

Authors:  Federica Dall'Oglio; Aurora Tedeschi; Francesco Lacarrubba; Gabriella Fabbrocini; Nevena Skroza; Paolo Chiodini; Giuseppe Micali
Journal:  J Cosmet Dermatol       Date:  2021-04       Impact factor: 2.696

Review 3.  Conventional and Novel Treatment Modalities in Rosacea.

Authors:  Burhan Engin; Defne Özkoca; Zekayi Kutlubay; Server Serdaroğlu
Journal:  Clin Cosmet Investig Dermatol       Date:  2020-02-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.